PRL as a novel potent cofactor for platelet aggregation

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 12, 2001, Pages 5912-5919

  Wallaschofski, H ^a   Donne M ^a   Eigenthaler, M ^a   Hentschel, B ^a   Faber, R ^a   Stepan, H ^a   Koksch, M ^a   Lohmann, T ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; PADGEM PROTEIN; PROLACTIN;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; HYPERCOAGULABILITY; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; LACTATION; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0035217821     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.12.8085     Document Type: Article

References (29)

1. Thrombosis in pregnancy
2. Thrombosis in pregnancy: Maternal and fetal issues
3. Risk factors for venous thrombotic disease
4. Venous thrombosis: A multicausal disease
5. Venous thromboembolism during pregnancy
6. Platelet-leukocyte cross talk in whole blood
7. P-Selectin expression on platelets determines size and stability of platelet aggregates
8. Plasma prolactin levels during pregnancy
9. Twenty-four hour prolactin (PRL) secretory patterns during pregnancy
10. Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytokfluorometry
11. From megakaryocytes to platelets: Platelet morphogenesis takes place in the bloodstream
12. Blood coagulation
13. Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man
14. Measurement of platelet activation by fluorescence-activated flow cytometry
15. Haemostatic derangement in advanced peripheral occlusive arterial disease
16. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass
17. Measures of clinical agreement for nominal and categorical data: The kappa coefficient
18. Hypophysectomized rats depend on residual prolactin for survival
19. Null mutation of the prolactin receptor gene produces a defect in maternal behavior
20. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse
21. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia
22. Antipsychotic drug use and risk of first-time idiopathic venous thromembolism: A case-control study
23. Plasma prolactin levels after TRH and chlorpromazine in normal subjects and patients with impaired pituitary function
24. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
25. Thrombin-stimulated phosphatidylinositol 3-kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: Activation of both enzymes is aggregation independent
26. Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets
27. Platelet-derivedgrowth-factor-induced signalling in human platelets: Phosphoinositide-3kinase-dependent inhibition of platelet activation
28. PI 3-kinase signalling in platelets: The significance of synergistic, autocrine stimulation
29. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF